XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Stockholder's Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Retained earnings (Accumulated deficit)
Beginning balance at Dec. 31, 2022 $ 341,373 $ 12 $ 330,100 $ 9 $ 11,252
Beginning balance, in shares at Dec. 31, 2022   115,218,229      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (6,100)       (6,100)
Share-based compensation 6,055   6,055    
Issuance of common stock under employee stock compensation plans, net (in shares)   366,291      
Issuance of common stock under employee stock compensation plans, net of tax (524)   (524)    
Unrealized net loss on available-for-sale securities (2)     (2)  
Ending balance, in shares at Mar. 31, 2023   115,584,520      
Ending balance at Mar. 31, 2023 340,802 $ 12 335,631 7 5,152
Beginning balance at Dec. 31, 2023 314,585 $ 12 353,890 50 (39,367)
Beginning balance, in shares at Dec. 31, 2023   116,859,468      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (18,961)       (18,961)
Share-based compensation 5,695   5,695    
Issuance of common stock under employee stock compensation plans, net (in shares)   529,321      
Issuance of common stock under employee stock compensation plans, net of tax 141   141    
Unrealized net loss on available-for-sale securities (67)     (67)  
Ending balance, in shares at Mar. 31, 2024   117,388,789      
Ending balance at Mar. 31, 2024 $ 301,393 $ 12 $ 359,726 $ (17) $ (58,328)